• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. PRINEO SKIN CLOSURE SYSTEM -US SURGICAL SEALANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. PRINEO SKIN CLOSURE SYSTEM -US SURGICAL SEALANT Back to Search Results
Catalog Number CLR602US
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Rash (2033); Skin Irritation (2076)
Event Date 09/28/2018
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4). To date, the device has not been returned. If the product is returned for evaluation, any further information derived from the evaluation will be submitted in a supplemental 3500a form. Additional information was requested and the following was obtained: what is the initial procedure date? (b)(6) 2018. How was the dermabond applied? dermabond liquid was applied in a thin layer on top of the skin (for dnx12) and on top to the tape(for clr602us). Excess liquid is wiped off the patient¿s skin. What layer of tissue was the dermabond applied to? dermabond was applied to the epidermis of the patient (for dnx12) and on top of the tape (for clr602us). How many layers of dermabond were applied? one. How was the prineo applied on the mesh? not fully understanding this question but if asking how was the liquid portion of the prineo applied to the mesh tape, it was applied in one thin layer. What prep was used prior to product application? chloroprep. Was a dressing placed over the incision? if so, what type of cover dressing used? no dressings on small incisions. Large abdominal incisions sometimes get abdominal binders. What date did the reaction occur on? reaction occurred (b)(6) 2018; what does the reaction look like and how large of an area does the reaction cover? the reaction is yellowish and rash-like. Was there any medical or surgical intervention performed (product removed; re-operation; re-closure; prescription steroids; antibiotics prescribed)? for case (b)(6) 2018, doctor was seeing and treating patient three times a week. The rash became less severe on (b)(6) 2018 but still appeared yellowish and rash-like. Can you identify the product code and lot number of the product that was used? codes were dnx12 and clr602us. No lot numbers were recorded. Is the patient hypersensitive or have allergies to cyanoacrylate or formaldehyde? not certain if patient is allergic to the aforementioned. Patient demographics: initials/id; age or date of birth; bmi; gender; patient pre-existing medical conditions (i. E. Allergies, history of reactions) ¿ patient is female.
 
Event Description
It was reported that a female patient underwent a plastic surgery procedure on (b)(6) 2018 and topical skin adhesive was used. The patient experienced a severe skin reaction which is yellowish and rash-like. The patient was seeing the doctor and was being treated three times a week. The rash became less severe on (b)(6) 2018 but still appeared yellowish and rash-like. Additional information was requested.
 
Manufacturer Narrative
Product complaint # : (b)(4). Additional information was requested and the following was obtained: do you have photos for the patient procedure date (b)(6) 2018 and patient procedure date (b)(6) 2017? no other photos do you have event dates or details for any additional patient events? no further information please describe where the dermabond and prineo 60 were used on each patient? yes, both were used on patient, but on different sections of the patient. Where specifically was the prineo 60 used on the patient? used on higher tension area panniculectomy section. Where was the dnx12 used on the patient? used on smaller incisions, used for the breast portion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NamePRINEO SKIN CLOSURE SYSTEM -US
Type of DeviceSURGICAL SEALANT
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
ETHICON INC.-SAN LORENZO
road 183, km. 8.3
san lorenzo PR
Manufacturer Contact
darlene kyle
p.o. box 151, route 22 west
somerville, NJ 08876-0151
9082182792
MDR Report Key8093366
MDR Text Key128031224
Report Number2210968-2018-77270
Device Sequence Number1
Product Code OMD
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K082289
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation
Type of Report Initial,Followup
Report Date 10/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/20/2018
Is this an Adverse Event Report? Yes
Device Operator
Device Catalogue NumberCLR602US
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received12/05/2018
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device?
Type of Device Usage Initial

Patient Treatment Data
Date Received: 11/20/2018 Patient Sequence Number: 1
-
-